Haberler & Etkinlikler
Global Action for Eye Health- World Sight Day 2024
In recognition of World Sight Day on October 10, ITN Business has launched a special program that we are proud to have participated in. The “Global Action for Eye Health” initiative focuses on worldwide efforts to enhance eye health, emphasizes the vital need for action, and features inspiring stories of innovation and impact from around the globe. Check out the RevitalVision video created for this important initiative.
Watch the video
August 2024
RevitalVision has been awarded the winner of the VSP Vision Innovation Challenge
VSP Vision, the leader in delivering access to health-focused vision care, and MATTER, the premier healthcare incubator and innovation hub, announce RevitalVision as the winner of the first-ever VSP Vision Innovation Challenge.
Read the announcement
June 2024
ESA-ISA 2024
We are thrilled to announce that Prof. Yair Morad will be presenting RevitalVision at the ESA-ISA 2024 Joint Meeting of the European and International Strabismological Associations, taking place in Toulouse France 13-15 June.
This event brings together the leading minds in pediatric ophthalmology, strabismus, orthoptic, and binocular vision, to share knowledge, exchange ideas, and explore the latest developments in these areas.
Professor Yair Morad will speak about Adult Amblyopia Treatment, sharing the latest clinical trial results withRevitalVision.
June 2024
RevitalVision on Israel21c
ISRAEL21C interviewed Yair Yahav, CEO of RevitalVision about RevitalVision’s home-based vision training program.
The article beautifully illustrates how our simple home-based brain training technology greatly enhances vision and quality of life for our patients
Read the full article
April 2024
Improving Vision in Congenital Nystagmus – Pivotal RCT Results – AAPOS 2024
During the scientific program at AAPOS 2024 in Boston, Dr. Idan Hecht presented the groundbreaking findings from a prospective randomized controlled trial evaluating the efficacy of RevitalVision in improving vision in Congenital Nystagmus patients. the study demonstrated statistically significant improvement in distance and near BCVA, and significant improvement in stereo and binocular functions, offering new hope for nystagmus patients, lacking alternative solutions to improve vision.
Watch presentation
March 2024
RevitalVision Post Crosslinking Surgery Study Won the Best ASCRS Scientific Poster Award
RevitalVision’s study on post crosslinking surgery patients won the best scientific poster award at ASCRS 2024, and was selected for a live presentation.
This prospective, controlled randomized study evaluated the efficacy of RevitalVision’s vision-training software- program in improving best corrected vision in stable keratoconus patients post crosslinking surgery, and showed remarkable clinical outcomes!
The results demonstrated significant improvement in vision, with a mean improvement of 2.5 VA lines, as well as improvements in contrast sensitivity function (CSF) among crosslinked keratoconus patients who received RevitalVision treatment.
We thank Prof. Lional Raj, Prof. David Heber and the rest of Dr.Agarwal’s Eye Hospital Research team for their awarded work!
Read the full abstract
BİZE ULAŞIN
Türkiye Distribütörü:Optik Medikal
Adres:Meşrutiyet Mah. Valikonağı Cad. Valikonağı Plaza B Blok 177/8 34363 Nişantaşı / İSTANBUL
Telefon:+90 212 225 90 50
Üretici Firma :Talshir Medical Technologies LTD
Hama’ayan Street 2, Modi’in 7177871, Israel
